Quick Answer
Skye Bioscience, Inc. reported Shares Outstanding of 33.38 million shares for fiscal year 2025.
Skye Bioscience, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 33.38M | +7.8% |
| 2024 | 30.97M | +150.8% |
| 2023 | 12.35M | +238.0% |
| 2022 | 3.65M | -99.2% |
| 2021 | 476.11M | +65.3% |
| 2020 | 288.07M | +57.5% |
| 2019 | 182.90M | +36.6% |
| 2018 | 133.91M | +298.3% |
| 2017 | 33.62M | +55.9% |
| 2016 | 21.56M | +8.3% |
| 2015 | 19.90M | +24.4% |
| 2014 | 16.00M | +105.9% |
| 2013 | 7.77M | +114.4% |
| 2013 | 3.62M | +43.4% |
| 2012 | 2.53M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 30.99M | +2.1% | +0.0% |
| June 30, 2025 | 30.99M | +10.4% | +0.0% |
| March 31, 2025 | 30.97M | +10.4% | +0.0% |
| December 31, 2024 | 30.97M | +150.8% | +2.1% |
| September 30, 2024 | 30.34M | +145.9% | +8.1% |
| June 30, 2024 | 28.07M | -97.1% | +0.0% |
| March 31, 2024 | 28.06M | -97.1% | +127.2% |
| December 31, 2023 | 12.35M | +238.0% | +0.1% |
- Skye Bioscience, Inc. showed an increase of +7.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2012–2025 period, Skye Bioscience, Inc.’s shares outstanding has grown by 1220.6% (from 2.53 million shares to 33.38 million shares).
- The most recent figure is from Skye Bioscience, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: